AI assistant
Streamex Corp. — Director's Dealing 2025
Jun 10, 2025
35540_dirs_2025-06-09_4df8e32e-3fd1-4170-8265-9545c28468d0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BioSig Technologies, Inc. (BSGM)
CIK: 0001530766
Period of Report: 2025-05-28
Reporting Person: McPhie Karl Henry Michael (Director, Chief Executive Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Exchangeable Shares | $ | Common Stock (21014450) | Indirect |
Footnotes
F1: Represents the common stock, par value $0.001 per share (the "Common Stock") of BioSig Technologies, Inc. (the "Company") that may be issued from time to time upon the exchange, retraction or redemption of exchangeable shares of BST Sub ULC, an unlimited liability company organized under the laws of the Province of British Columbia and a wholly-owned subsidiary of the Company (the "Exchangeable Shares"). Each Exchangeable Share may be exchanged for one share of Common Stock, subject to certain exceptions. The aggregate number of Exchangeable Shares that may be exchanged for Common Stock may not exceed 19.9% of the total outstanding Common Stock until such issuance is approved by the Company's stockholders. The Exchangeable Shares do not have an expiration date.
F2: Represents shares of Common Stock held by an entity for which the Reporting Person holds voting and dispositive control.